|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1995-6-27
|
|
pubmed:abstractText |
To evaluate the efficacy of immunopurified class I human histocompatibility leukocyte antigen (HLA) to protect against SIV infection.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0269-9370
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
223-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:7755909-Animals,
pubmed-meshheading:7755909-Antibodies, Viral,
pubmed-meshheading:7755909-Down-Regulation,
pubmed-meshheading:7755909-Histocompatibility Antigens Class I,
pubmed-meshheading:7755909-Humans,
pubmed-meshheading:7755909-Immunity, Cellular,
pubmed-meshheading:7755909-Lymphocyte Activation,
pubmed-meshheading:7755909-Macaca fascicularis,
pubmed-meshheading:7755909-Simian Acquired Immunodeficiency Syndrome,
pubmed-meshheading:7755909-Simian immunodeficiency virus,
pubmed-meshheading:7755909-T-Lymphocytes,
pubmed-meshheading:7755909-Vaccination,
pubmed-meshheading:7755909-Virion,
pubmed-meshheading:7755909-Virus Replication
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Immunization with class I human histocompatibility leukocyte antigen can protect macaques against challenge infection with SIVmac-32H.
|
|
pubmed:affiliation |
National Institute for Biological Standards and Control, South Mimms, Potters Bar, UK.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
